When a clinical trial starts to struggle, the conversation almost always turns to enrollment, with recruitment numbers running low and retention becoming increasingly difficult to maintain as timelines slip and pressure mounts. Sponsors and study teams begin asking how enrollment can be improved, accelerated, or rescued, often treating it as the central problem that needs to be solved.

But after more than fifteen years working inside clinical research operations across academic medical centers, industry-sponsored trials, and multi-site studies, I have come to believe something uncomfortable about all of this. Many trials are already struggling long before enrollment begins to fail. The operational cracks often appear quietly at the beginning. A protocol may be scientifically strong but operationally unrealistic. Study teams inherit timelines disconnected from clinical workflow realities. Communication becomes fragmented across sponsors, contract research organizations (CROs), investigators, coordinators, and regulatory teams. Small inefficiencies accumulate long before recruitment numbers visibly decline.

Then the study opens.

At first, everything looks fine. Meetings happen, metrics get reported, and timelines move forward. Behind the scenes, the operational burden starts shifting onto the people closest to the work, including coordinators, nurses, project managers, regulatory staff, data teams, and eventually patients themselves. By the time enrollment visibly struggles, deeper structural problems may have existed for months.

This is not a criticism of the people working inside clinical research. Across my career, I have worked beside extraordinary coordinators, investigators, sponsors, and study teams. The issue is not a lack of intelligent or committed professionals. The issue is that modern clinical research systems often rely on unsustainable human adaptation to compensate for operational complexity.

Clinical research has become extraordinarily sophisticated scientifically, but many operational systems still depend on people quietly absorbing inefficiencies in order to keep studies functioning. Much of that invisible labor never appears in publications, dashboards, or executive summaries, even though it often determines whether a study remains stable, and when it fails, the costs are real.

Beata Pasek health researcher.